Search results for: 'Hematology therapeutic market antibody'
- Did you mean
- hematology therapeutic market antibodi
- Related search terms
- market analysis of rf energy harvesting technolog
- marketing strategy homes industry year 16.9
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
19 Aug 2022  |  North America  |  Market Research
Global Antibody Therapeutics Growth Opportunities
The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth
Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...
$2,450.00
Special Price $1,837.50 save 25 %
-
25 Jul 2024  |  Global  |  Technology Research
Engineered Antibody Therapeutics for Cancer
Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies
This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Sep 2026  |  Global  |  Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Technology Advancements, Clinical Progress, and Growth Opportunities in AI-Enabled Antibody Therapeutics
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...
$4,950.00 -
07 Nov 2017  |  North America  |  Market Research
Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021
Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success
The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hosp...
$1,500.00
Special Price $1,125.00 save 25 %
-
21 Dec 2022  |  Global  |  Technology Research
Antibody-drug Conjugates: Technology Growth Opportunities
Disruptive Technologies and a Conducive Funding Environment are Fostering Growth
Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Apr 2023  |  Global  |  Technology Research
Technology Innovations and Growth Opportunities in Inhaled Therapeutics
Nanoparticle-based Formulation to Drive Transformational Growth Across Inhaled Vaccines and Monoclonal Antibodies
Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jul 2025  |  Global  |  Technology Research
Growth Opportunities in RNA Therapeutics
Broad Applications Drive Growth in RNA Therapeutics
The report analyzes clinical trial activity across RNA therapeutic classes, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASO), aptamers, micro RNA (miRNA), self-amplifying RNA (saRNA), small-activating RNA (RNAa), and circular RNA (cirRNA). It highlights key players in each segment and their role in adv...
$4,950.00 -
17 Jul 2023  |  Global  |  Market Research
Global Antibody Drug Conjugate (ADC) Growth Opportunities, Forecast to 2028
Collaborations with Innovative Platform Developers will Drive Growth Potential
This research service overviews the global ADC market and provides a 6-year revenue forecast from 2023 to 2028. An ADC comprises multiple components such as the antibody, conjugation chemistry, linker, and payload. Many companies are working on each component while others only develop ADCs, which makes the market highly competitive. The development...
$2,450.00
Special Price $1,837.50 save 25 %
-
08 Jul 2026  |  Global  |  Technology Research
Digital Therapeutics for Chronic Conditions
From Apps to Digital Interventions to Clinically-Regulated Prescription Digital Therapeutics
This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...
$4,950.00 -
02 Dec 2025  |  Global  |  Frost Radar
Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...
$4,950.00